from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2351c/plcA

LFCtreatmentdescriptionclass of inhibitor

-0.219

Amikacinug/mL Amikacintranslation

0.248

Cap5-10ug/mL Capreomycintranslation

0.135

Rox10-50 ug/mL Roxithromycintranslation

-0.859

SM2-5 ug/mL Streptomycintranslation

0.117

Tet5-10 ug/mL Tetracyclinetranslation

1.252

Rif0.2-5ug/mL Rifampicintranscription

-0.232

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.753

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.969

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.104

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.483

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.274

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.011

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.845

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.871

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.304

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.035

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.784

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.398

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.833

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.925

KCN5-20 ug/mL Potassium cyaniderespiration

-0.391

NaN30.2-2 mM Sodium aziderespiration

0.650

Nigericin50 uM Nigericinrespiration

0.432

TRC10-150 ug/mL Triclosanrespiration

0.762

TRZ10-25 ug/mL Thioridazinerespiration

-1.424

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.631

menadione6-10 ug/mL Menadionerespiration

-0.396

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.483

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.135

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.639

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.947

NRP_1Non-replicating persistence stage 1dosRassociated

0.628

Amp0.2mg/mL AmpicillincellWall

0.851

Cephalexin20-100 ug/mL CephalexincellWall

0.142

Cerulenin0.32-5 ug/mL CerulenincellWall

0.534

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.378

EMB10-20 ug/mL EthambutolcellWall

0.100

Eta12-40 ug/mL EthionamidecellWall

-0.132

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.097

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.504

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.530

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.631

BZA0.12 mg/mL BenzamidearomaticAmides

0.038

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.020

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.315

H2O24 mM hydrogen peroxideDNAdamaging

0.002

Levo10 ug/mL LevofloxacinDNAdamaging

-0.417

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.495

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.348

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.297

UVUV-irradiationDNAdamaging

-2.198

ARP41-4 ug/mL Antitubercular compound ARP4?

0.120

Antimycin12.5-50 ug/mL Antimycin A?

1.096

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.769

PA_110-50 ug/mL Antitubercular compound PA-1?

0.605

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.039

PA8240.2-2 ug/mL PA-824?

0.481

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.282

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.971

Verapamil50 uM Verapamil?

0.801

mercaptoethanol2 mM 2-Mercaptoethanol?

1.701

methoxatin10-20 ug/mL Methoxatin?